Developing a new cancer medicine is neither quick nor easy. It requires a multi-billion dollar investment and, on average, takes more than a decade. What's more, there's no guarantee that a molecule will develop into a medicine-- out of every 10,000 molecules researched, only one becomes a treatment for patients.
Despite these hurdles, scientists and companies around the world work tirelessly to find the next step forward in anti-cancer innovation. Since 1990, cancer mortality rates have fallen by over 20%, and the number of cancer survivors in the US has more than doubled. Every May, the American Association for Cancer Research (AACR) celebrates these accomplishments and encourages future progress during National Cancer Research Month.
In our latest infographic, we take a look at the complex and lengthy process of developing a medicine to treat cancer and the unique challenges facing researchers working on treatments for the 13 million Americans living with cancer today.
Don't forget to join the conversation on the importance of cancer research on Twitter using #NCRM14!